Guardian Pharmacy Services, Inc. (GRDN) stock
GRDNNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30160% above fair value
$50.33+0.90 (+1.82%)
Close on Nov 17, 2026Market cap $3.19BP/E –Yield –
Guardian Pharmacy Services revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Guardian Pharmacy Services's revenue for the twelve months ending Jun 30, 2026 was $1.46B, up 10.3% year over year. For fiscal 2025 it was $1.45B, up 17.9% from the year before.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.45B | +17.9% |
| FY2024 | Dec 31, 2024 | $1.23B | +17.4% |
| FY2023 | Dec 31, 2023 | $1.05B | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $351.77M | +2.2% |
| Q1 FY2026 | Mar 31, 2026 | $336.60M | +2.2% |
| Q4 FY2025 | Dec 31, 2025 | $397.62M | +17.4% |
| Q3 FY2025 | Sep 30, 2025 | $377.43M | +20.0% |
| Q2 FY2025 | Jun 30, 2025 | $344.33M | +14.8% |
| Q1 FY2025 | Mar 31, 2025 | $329.31M | +19.6% |
| Q4 FY2024 | Dec 31, 2024 | $338.57M | +20.5% |
| Q3 FY2024 | Sep 30, 2024 | $314.39M | +19.7% |
| Q2 FY2024 | Jun 30, 2024 | $300.04M | – |
| Q1 FY2024 | Mar 31, 2024 | $275.41M | – |
| Q4 FY2023 | Dec 31, 2023 | $281.07M | – |
| Q3 FY2023 | Sep 30, 2023 | $262.74M | – |
See a number that looks wrong?